Paul Riska

Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans

Paul Riska, Michael Lamson, Thomas R. MacGregor et al. · Drug Metabolism and Disposition · 1999 · 223 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 160 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic <i>Clostridium difficile</i> Infection

Elizabeth Jean Kvach, David Ferguson, Paul Riska et al. · Journal of Clinical Microbiology · 2009 · 138 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +16

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3